What is Ayass BioScience?
Ayass BioScience, LLC is a specialized entity focused on causal biomarker discovery and advanced clinical laboratory testing. Leveraging proprietary BiRAGAS and Aptamer platforms, the company champions translational innovation within the research and healthcare sectors. Its core mission is to deliver intelligent biological solutions that move beyond mere correlation, providing clients with actionable insights into complex biological processes. The company's commitment to research and development positions it as a key player in advancing scientific understanding and clinical applications.
How much funding has Ayass BioScience raised?
Ayass BioScience has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Ayass BioScience
PPP
Public-Private Partnership
What's next for Ayass BioScience?
With the recent influx of capital from a major strategic investment, Ayass BioScience is poised for accelerated growth and enhanced market penetration. This large-scale, late-stage funding suggests a strategic focus on scaling operations, expanding research initiatives, and potentially broadening its service offerings. The company is likely to invest further in its technological platforms and clinical testing capabilities to solidify its position as a leader in biomarker discovery and biological solutions. Future developments may include strategic partnerships and the commercialization of new diagnostic tools.
See full Ayass BioScience company page
